
0:00
4:34
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
Altri episodi di "Illumina Genomics Podcast"



Non perdere nemmeno un episodio di “Illumina Genomics Podcast”. Iscriviti all'app gratuita GetPodcast.








